# IOVANCE BIOTHERAPEUTICS, INC. (IOVA) FY2026 YTD Q2 P&L / Income Statement

- Company: IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001104659-26-091716
- Page: https://plicit.ai/financials/iova/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/iova-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 170,743,000 US dollars
- **Cost of sales**: 86,093,000 US dollars
- **Gross profit (calculated)**: 84,650,000 US dollars
- **Operating expenses (calculated)**: 217,598,000 US dollars
- **Loss from operations**: negative 132,948,000 US dollars
- **Other income (expense), net (calculated)**: 4,550,000 US dollars
- **Net Loss before income taxes**: negative 128,398,000 US dollars
- **Income tax benefit (expense)**: negative 2,038,000 US dollars
- **Net Loss**: negative 126,360,000 US dollars
- **Amtagvi**: 150,943,000 US dollars
- **Proleukin**: 19,800,000 US dollars
- **Research and development**: 121,338,000 US dollars
- **Selling, general, and administrative**: 78,221,000 US dollars
- **Depreciation and amortization**: 18,039,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/iova/fy2026-ytd-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/iova-fy2026-ytd-q2-revenue-by-geography-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 170,743,000 US dollars
- **Cost of sales**: 86,093,000 US dollars
- **Gross profit (calculated)**: 84,650,000 US dollars
- **Operating expenses (calculated)**: 217,598,000 US dollars
- **Loss from operations**: negative 132,948,000 US dollars
- **Other income (expense), net (calculated)**: 4,550,000 US dollars
- **Net Loss before income taxes**: negative 128,398,000 US dollars
- **Income tax benefit (expense)**: negative 2,038,000 US dollars
- **Net Loss**: negative 126,360,000 US dollars
- **UNITED STATES**: 169,439,000 US dollars
- **Rest of world**: 1,304,000 US dollars
- **Research and development**: 121,338,000 US dollars
- **Selling, general, and administrative**: 78,221,000 US dollars
- **Depreciation and amortization**: 18,039,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.